iridium radioisotopes has been researched along with Proctitis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HC; Fang, FM; Hsu, HC; Huang, EY; Huang, YJ; Lan, JH; Wang, CJ; Wang, CY; Wang, YM | 1 |
| Chanchien, CC; Huang, EY; Huang, YJ; Lan, JH; Lin, H; Sun, LM; Wang, CJ; Wang, CY | 1 |
| Fujii, T; Fujisawa, M; Hiratsuka, J; Jo, Y; Takenaka, A | 1 |
| Dobbins, T; Fogarty, GB; Haddad, RL; Izard, MA; Katelaris, P; Rinks, A | 1 |
| Ali, MM; Hackler, RH; Klein, FA; Marks, SE | 1 |
1 trial(s) available for iridium radioisotopes and Proctitis
| Article | Year |
|---|---|
High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Brachytherapy; Combined Modality Therapy; Cystitis; Disease-Free Survival; Dose Fractionation, Radiation; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Proctitis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, High-Energy; Treatment Outcome | 2004 |
4 other study(ies) available for iridium radioisotopes and Proctitis
| Article | Year |
|---|---|
Factors for predicting rectal dose of high-dose-rate intracavitary brachytherapy after pelvic irradiation in patients with cervical cancer: a retrospective study with radiography-based dosimetry.
Topics: Adenocarcinoma; Brachytherapy; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Middle Aged; Proctitis; Radiation Injuries; Radiography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Rectum; Regression Analysis; Relative Biological Effectiveness; Retrospective Studies; Uterine Cervical Neoplasms | 2010 |
A prospective cohort study to compare treatment results between 2 fractionation schedules of high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer.
Topics: Age Factors; Aged; Brachytherapy; Cystitis; Dose Fractionation, Radiation; Enterocolitis; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Middle Aged; Proctitis; Prospective Studies; Radiation Injuries; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Six year experience of external beam radiotherapy, brachytherapy boost with a 1Ci (192)Ir source, and neoadjuvant hormonal manipulation for prostate cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoadjuvant Therapy; Proctitis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Survival Analysis; Time Factors; Treatment Failure; Urogenital System | 2006 |
Bilateral pelvic lymphadenectomy, iridium 192 template, and external beam therapy for localized prostatic carcinoma: complications and results.
Topics: Adenocarcinoma; Aged; Brachytherapy; Combined Modality Therapy; Humans; Iridium Radioisotopes; Lymph Node Excision; Male; Middle Aged; Pelvis; Postoperative Complications; Proctitis; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Dosage | 1988 |